Emerging antifungal resistance: an updated review on current scenario, pathogens involved and tackling strategies

Sanchita Mitra1,2

  • 1Jhaveri Microbiology Centre and Prof. Brien Holden Eye Research Centre, LV Prasad Eye Institute, Hyderabad, India.

Future Microbiology
|May 12, 2026
PubMed

Insights

Antifungal resistance (AFR) is a growing global threat, exacerbated by limited diagnostics and treatments. This review addresses key challenges and novel strategies for managing AFR in humans and animals.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Public Health

Background:

  • Antifungal resistance (AFR) is an escalating global health concern, yet it receives less attention than antibacterial resistance.
  • AFR incidence is rising in both immunocompromised and immunocompetent individuals, complicated by factors like zoonotic potential and limited diagnostics.

Purpose of the Study:

  • To compile current information, advances, and perspectives on the major challenges in the origin and management of antifungal resistance.
  • To systematically review existing literature on antifungal resistance, focusing on environmental drivers, the "One Health" perspective, and climate change impacts.

Main Methods:

  • Conducted a systematic review of publications on standard databases using search terms related to antifungal resistance up to January 2026.
  • Focused on key aspects including environmental drivers, "One Health," climate change, fungal zoonoses, diagnostics, resistant pathogens, stewardship, and novel strategies.

Main Results:

  • Identified significant challenges in AFR management, including limited diagnostics, a narrow antifungal pipeline, and cross-resistance issues.
  • Highlighted the need for robust antifungal stewardship programs and explored emerging fungal zoonoses and their links to environmental factors.

Conclusions:

  • AFR presents a complex, multifaceted threat requiring a "One Health" approach, integrating human, animal, and environmental health strategies.
  • Novel strategies, including mycoviruses and vaccines, show promise for combating AFR, alongside improved diagnostics and stewardship.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Overview of Fungi01:29

Overview of Fungi

Fungi are a diverse group of eukaryotes more closely related to animals than other eukaryotes. Fungal cell walls comprise chitin, a polysaccharide that provides structural strength, and glucans, which contribute to flexibility and integrity. Other polysaccharides, such as mannans and galactosans, may supplement or replace chitin in some fungi. These adaptations, along with their preference for acidic environments and tolerance for high osmotic pressure, enable fungi to thrive in various...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...